At the heart of the effort to develop these therapies are scientists like Glenn. For them, Covid is a chance to prove that they can make a difference...
Mireille Kamariza, CEO of OliLux Biosciences — which recently received an investment from Open Philanthropy — is working on a potential breakthrough diagnostic tool to fight tuberculosis.
In her role at the Broad Institute, Open Philanthropy grantee Pardis Sabeti worked with Colorado Mesa University to develop a system for pandemic management, versions of which may...
